|
1
|
Blanco MA and Kang Y: Signaling pathways
in breast cancer metastasis - novel insights from functional
genomics. Breast Cancer Res. 13:2062011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yang M, Chen J, Su F, Yu B, Su F, Lin L,
Liu Y, Huang JD and Song E: Microvesicles secreted by macrophages
shuttle invasion-potentiating microRNAs into breast cancer cells.
Mol Cancer. 10:1172011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chaffer CL and Weinberg RA: A perspective
on cancer cell metastasis. Science. 331:1559–1564. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li L, Luo J, Wang B, Wang D, Xie X, Yuan
L, Guo J, Xi S, Gao J, Lin X, et al: MicroRNA-124 targets
flotillin-1 to regulate proliferation and migration in breast
cancer. Mol Cancer. 12:1632013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Burstein HJ, Griggs JJ, Prestrud AA and
Temin S: American Society of Clinical Oncology clinical practice
guideline update on adjuvant endocrine therapy for women with
hormone receptor-positive breast cancer. J Oncol Pract. 6:243–246.
2010. View Article : Google Scholar :
|
|
6
|
Dawood S, Merajver SD, Viens P, Vermeulen
PB, Swain SM, Buchholz TA, Dirix LY, Levine PH, Lucci A,
Krishnamurthy S, et al: International expert panel on inflammatory
breast cancer: Consensus statement for standardized diagnosis and
treatment. Ann Oncol. 22:515–523. 2011. View Article : Google Scholar :
|
|
7
|
Ashok M, Griffin P and Halpern M: Impact
of clinical and nonclinical factors on the choice of HER2 test for
breast cancer. Cancer Invest. 28:735–742. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lee JE, Kim HJ, Bae JY, Kim SW, Park JS,
Shin HJ, Han W, Kim SW, Kang KS and Noh DY: Neogenin expression may
be inversely correlated to the tumorigenicity of human breast
cancer. BMC Cancer. 5:1542005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fitzgerald DP, Bradford D and Cooper HM:
Neogenin is expressed on neurogenic and gliogenic progenitors in
the embryonic and adult central nervous system. Gene Expr Patterns.
7:784–792. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yamashita T, Mueller BK and Hata K:
Neogenin and repulsive guidance molecule signaling in the central
nervous system. Curr Opin Neurobiol. 17:29–34. 2007. View Article : Google Scholar
|
|
11
|
Matsunaga E and Chedotal A: Repulsive
guidance molecule/neogenin: A novel ligand-receptor system playing
multiple roles in neural development. Dev Growth Differ.
46:481–486. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lejmi E, Leconte L, Pédron-Mazoyer S,
Ropert S, Raoul W, Lavalette S, Bouras I, Feron JG, Maitre-Boube M,
Assayag F, et al: Netrin-4 inhibits angiogenesis via binding to
neogenin and recruitment of Unc5B. Proc Natl Acad Sci USA.
105:12491–12496. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wilson NH and Key B: Neogenin: One
receptor, many functions. Int J Biochem Cell Biol. 39:874–878.
2007. View Article : Google Scholar
|
|
14
|
Cole SJ, Bradford D and Cooper HM:
Neogenin: A multifunctional receptor regulating diverse
developmental processes. Int J Biochem Cell Biol. 39:1569–1575.
2007. View Article : Google Scholar
|
|
15
|
Wilson NH and Key B: Neogenin interacts
with RGMa and netrin-1 to guide axons within the embryonic
vertebrate forebrain. Dev Biol. 296:485–498. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kim SJ, Wang YG, Lee HW, Kang HG, La SH,
Choi IJ, Irimura T, Ro JY, Bresalier RS and Chun KH: Up-regulation
of neogenin-1 increases cell proliferation and motility in gastric
cancer. Oncotarget. 5:3386–3398. 2014.PubMed/NCBI
|
|
17
|
Link BC, Reichelt U, Schreiber M, Kaifi
JT, Wachowiak R, Bogoevski D, Bubenheim M, Cataldegirmen G, Gawad
KA, Issa R, et al: Prognostic implications of netrin-1 expression
and its receptors in patients with adenocarcinoma of the pancreas.
Ann Surg Oncol. 14:2591–2599. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Song S, Mazurek N, Liu C, Sun Y, Ding QQ,
Liu K, Hung MC and Bresalier RS: Galectin-3 mediates nuclear
beta-catenin accumulation and Wnt signaling in human colon cancer
cells by regulation of glycogen synthase kinase-3beta activity.
Cancer Res. 69:1343–1349. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hu YC, Lam KY, Law S, Wong J and
Srivastava G: Identification of differentially expressed genes in
esophageal squamous cell carcinoma (ESCC) by cDNA expression array:
Overexpression of Fra-1, Neogenin, Id-1, and CDC25B genes in ESCC.
Clin Cancer Res. 7:2213–2221. 2001.PubMed/NCBI
|
|
20
|
Wu X, Li Y, Wan X, Kayira TM, Cao R, Ju X,
Zhu X and Zhao G: Down-regulation of neogenin accelerated glioma
progression through promoter methylation and its overexpression in
SHG-44 induced apoptosis. PLoS One. 7:e380742012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fujita Y, Taniguchi J, Uchikawa M, Endo M,
Hata K, Kubo T, Mueller BK and Yamashita T: Neogenin regulates
neuronal survival through DAP kinase. Cell Death Differ.
15:1593–1608. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bolos V, Blanco M, Medina V, Aparicio G,
Diaz-Prado S and Grande E: Notch signalling in cancer stem cells.
Clin Transl Oncol. 11:11–19. 200PubMed/NCBI
|
|
23
|
Zardawi SJ, O’Toole SA, Sutherland RL and
Musgrove EA: Dysregulation of Hedgehog, Wnt and Notch signalling
pathways in breast cancer. Histol Histopathol. 24:385–398.
2009.PubMed/NCBI
|
|
24
|
Hagihara M, Endo M, Hata K, Higuchi C,
Takaoka K, Yoshikawa H and Yamashita T: Neogenin, a receptor for
bone morphogenetic proteins. J Biol Chem. 286:5157–5165. 2011.
View Article : Google Scholar :
|
|
25
|
Yang ZQ, Liu G, Bollig-Fischer A, Haddad
R, Tarca AL and Ethier SP: Methylation-associated silencing of
SFRP1 with an 8p11–12 amplification inhibits canonical and
non-canonical WNT pathways in breast cancers. Int J Cancer.
125:1613–1621. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang ZQ, Streicher KL, Ray ME, Abrams J
and Ethier SP: Multiple interacting oncogenes on the 8p11–p12
amplicon in human breast cancer. Cancer Res. 66:11632–11643. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang ZQ, Imoto I, Fukuda Y, Pimkhaokham A,
Shimada Y, Imamura M, Sugano S, Nakamura Y and Inazawa J:
Identification of a novel gene, GASC1, within an amplicon at
9p23–24 frequently detected in esophageal cancer cell lines. Cancer
Res. 60:4735–4739. 2000.PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
29
|
Feng X, Wu Z, Wu Y, Hankey W, Prior TW, Li
L, Ganju RK, Shen R and Zou X: Cdc25A regulates matrix
metalloprotease 1 through Foxo1 and mediates metastasis of breast
cancer cells. Mol Cell Biol. 31:3457–3471. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang Y, Chen X, Qiao M, Zhang BQ, Wang N,
Zhang Z, Liao Z, Zeng L, Deng Y, Deng F, et al: Bone morphogenetic
protein 2 inhibits the proliferation and growth of human colorectal
cancer cells. Oncol Rep. 32:1013–1020. 2014.PubMed/NCBI
|
|
31
|
Hardwick JC, van den Brink GR, Bleuming
SA, Ballester I, van den Brande JM, Keller JJ, Offerhaus GJ, van
Deventer SJ and Peppelenbosch MP: Bone morphogenetic protein 2 is
expressed by, and acts upon, mature epithelial cells in the colon.
Gastroenterology. 126:111–121. 2004. View Article : Google Scholar
|
|
32
|
Hu Y, Du Y, Jiang H and Jiang GS: Cerium
promotes bone marrow stromal cells migration and osteogenic
differentiation via Smad1/5/8 signaling pathway. Int J Clin Exp
Pathol. 7:5369–5378. 2014.PubMed/NCBI
|
|
33
|
Engebraaten O, Vollan HK and Borresen-Dale
AL: Triplenegative breast cancer and the need for new therapeutic
targets. Am J Pathol. 183:1064–1074. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li N, Zheng RS, Zhang SW, Zou XN, Zeng HM,
Dai Z and Chen WQ: Analysis and prediction of breast cancer
incidence trend in China. Zhonghua Yu Fang Yi Xue Za Zhi.
46:703–707. 2012.in Chinese. PubMed/NCBI
|
|
35
|
Yang S and Han H: Effect of
cycloxygenase-2 silencing on the malignant biological behavior of
MCF-7 breast cancer cells. Oncol Lett. 8:1628–1634. 2014.PubMed/NCBI
|
|
36
|
Veeck J, Noetzel E, Bektas N, Jost E,
Hartmann A, Knüchel R and Dahl E: Promoter hypermethylation of the
SFRP2 gene is a high-frequent alteration and tumor-specific
epigenetic marker in human breast cancer. Mol Cancer. 7:832008.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang X and Munster PN: New protein kinase
inhibitors in breast cancer: afatinib and neratinib. Expert Opin
Pharmacother. 15:1277–1288. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
De Los Santos JF, Cantor A, Amos KD,
Forero A, Golshan M, Horton JK, Hudis CA, Hylton NM, McGuire K,
Meric-Bernstam F, et al: Magnetic resonance imaging as a predictor
of pathologic response in patients treated with neoadjuvant
systemic treatment for operable breast cancer. Translational Breast
Cancer Research Consortium trial 017. Cancer. 119:1776–1783. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Meyerhardt JA, Look AT, Bigner SH and
Fearon ER: Identification and characterization of neogenin, a
DCC-related gene. Oncogene. 14:1129–1136. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Latil A, Chêne L, Cochant-Priollet B,
Mangin P, Fournier G, Berthon P and Cussenot O: Quantification of
expression of netrins, slits and their receptors in human prostate
tumors. Int J Cancer. 103:306–315. 2003. View Article : Google Scholar
|
|
41
|
Li VS, Yuen ST, Chan TL, Yan HH, Law WL,
Yeung BH, Chan AS, Tsui WY, So S, Chen X, et al: Frequent
inactivation of axon guidance molecule RGMA in human colon cancer
through genetic and epigenetic mechanisms. Gastroenterology.
137:176–187. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ye L, Lewis-Russell JM, Kyanaston HG and
Jiang WG: Bone morphogenetic proteins and their receptor signaling
in prostate cancer. Histol Histopathol. 22:1129–1147.
2007.PubMed/NCBI
|
